@article{oai:u-ryukyu.repo.nii.ac.jp:02015641,
 author = {Hokama, Akira and Sho, Yoshiyuki and Muto, Yoshihiro and Yamauchi, Kazuo and Kurihara, Kotaro and Yamazato, Masahito and Hidaka, Osamu and Kaida, Kazuhiro},
 issue = {1},
 journal = {琉球大学医学会雑誌 : 医学部紀要 = Ryukyu medical journal},
 month = {},
 note = {We have administered by rectumFT 207 to inoperable cases, recurrent cases or those cases who had undergone palliative operation. Twenty three cases were treated with this method: nine cases of gastric cancer, four cases of colon cancer, four cases of rectal cancer, three cases of hepatoma, a case of biliary tract cancer, a case of liver metastasis from esophageal cancer, and a case of cancer of the anus. Daily dosage was 750 mg or 1500 mg, and the total dose ranged from 15.5g to 574.5g. Other drugs (Neocarcinostatin or Mitomycin C and Picibanil or Kresin) were also administered. According to Karnofsky's criteria, the results were as follows:six cases of O-O, a case of O-A, none of O-B. a case of O-C, seven of 1-A, four cases of 1-B, two cases of 1-C and two of unknown classification. A total of thirteen of the twenty one cases showed more than 1-A., 論文},
 pages = {12--18},
 title = {[原著］Clinical Study of Rectal Administration of FT 207 in Patients with Advanced Gastromtestinal Cancer},
 volume = {6},
 year = {1983}
}